Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted by the Regulatory Affairs Professional Society in “FDA Expresses Desire to Work with Industry on CGMPs for Combo Products,” by Zachary Brousseau.
Following is an excerpt:
This was the third RAPS/CPC CGMPs for combo products in the past six years, and all have provided a similar opportunity to interact directly with FDA officials. Commenting about the previous workshop, one of the event’s organizers, Brad Thompson of Epstein Becker & Green, said during his opening remarks, “I found it incredibly helpful as we prepared our comments, to be able to ask questions.”
An audio recording of the workshop is also provided. Mr. Thompson's comments start circa 5:00.
